Due to its role in macrophage polarization and regulation of inflammation, PPARγ has become an attractive pharmacological target for the development of drugs used for the treatment of metabolic disease in which activated macrophages play prominent pathogenic roles. The gene discussed is PPARG; the disease is metabolic disease.